SAN DIEGO & TORONTO–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP reminds investors that a purchaser of PharmaCielo Ltd. (OTC: PCLOF) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between June 21, 2019 and March 2, 2020. PharmaCielo, through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medical-grade cannabis oil extracts and related products in Colombia and internationally.

If you suffered a loss as a result of PharmaCielo’s misconduct, click here.

PharmaCielo Ltd. (PCLOF) Accused of Misleading Shareholders

According to the complaint, in September 2019, PharmaCielo issued a press release announcing that it “ha[d] signed a United States sales agreement with an established multi-state distributor, General Extract LLC.” Following this announcement, in November 2019, PharmaCielo released its Company’s third quarter 2019 financial statements touting that it was “nearing completion of [its] extraction and processing center (‘RTC’), which will expand the Company’s extraction capacity.” While PharmaCielo’s November financial statements purported to list all of the Company’s related party transactions, on March 2, 2020, Hindenburg Research reported that General Extract LLC was a related party entity with no credible operations run by PharmaCielo’s former COO. The report further asserted that PharmaCielo had engaged in misleading business transactions with General Extract and Xphyto Therapeutics, and questioned the delayed development of its processing center and general misinformation regarding its production facilities. Since this news, shares of PharmaCielo have declined 56% per share, currently trading at around $0.60 per share.

PharmaCielo Ltd. (PCLOF) Shareholders Have Legal Options

Contact us to learn more:

Leo Kandinov

(800) 350-6003

lkandinov@robbinsllp.com

Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.